Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Blackrock Inc (BLK) vs GeneDx Holdings Corp (WGS) Price & Performance

Blackrock IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Blackrock Inc vs GeneDx Holdings Corp — how do they compare? Blackrock Inc trades at $1,148.43 (market cap $177.92B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Blackrock Inc is far larger — about 72.9× GeneDx Holdings Corp's market cap, and Blackrock Inc pays a 2% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

BLKWGS
Market Cap
$177.92B$2.44B
Volume
641,547
Sector
FinancialsTechnology
52-Week High
$1.20K$167.51
52-Week Low
$922.90$34.51
Enterprise Value
$179.02B$2.48B
Dividend Yield
2%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Blackrock Inc

BLK trades at $1,131.40, down slightly by 0.44% today, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $24.22 billion for 2025, with net income of $5.55 billion, and has consistently beaten EPS estimates in recent quarters. Recent news highlights BlackRock's involvement in a major AI financing initiative with Nvidia and other firms.

The outlook remains positive given strong earnings performance and a consensus buy rating from analysts, with a price target of $1,350. Key risks include potential legal challenges from investor lawsuits and volatile cash flow trends, but institutional confidence and strategic partnerships provide a solid foundation for growth.

GeneDx Holdings Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Blackrock Inc

BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.

Read more on BLK

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS